KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Times Interest Earned (2017 - 2022)

Sarepta Therapeutics (SRPT) has 6 years of Times Interest Earned data on record, last reported at -$8.41 in Q4 2022.

  • For Q4 2022, Times Interest Earned rose 11.26% year-over-year to -$8.41; the TTM value through Sep 2023 reached -$31.44, down 203.78%, while the annual FY2023 figure was -$12.17, 20.84% down from the prior year.
  • Times Interest Earned reached -$8.41 in Q4 2022 per SRPT's latest filing, up from -$15.06 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $31.12 in Q4 2019 and bottomed at -$319.45 in Q2 2019.
  • Average Times Interest Earned over 5 years is -$21.92, with a median of -$9.82 recorded in 2020.
  • Peak YoY movement for Times Interest Earned: soared 153.54% in 2018, then crashed 2415.72% in 2019.
  • A 5-year view of Times Interest Earned shows it stood at $18.64 in 2018, then soared by 66.98% to $31.12 in 2019, then plummeted by 151.01% to -$15.87 in 2020, then skyrocketed by 40.29% to -$9.48 in 2021, then increased by 11.26% to -$8.41 in 2022.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$8.41 in Q4 2022, -$15.06 in Q3 2022, and -$13.17 in Q2 2022.